QR Kodea

Self-Administration of Long-Acting Somatostatin Analogues in NET Patients—Does It Affect the Clinical Outcome?

<i>Background and Objectives</i>: Long-acting somatostatin analogues (SSA) (octreotide LAR and lanreotide Autogel) are recommended as first line treatment of locally advanced or metastatic well-differentiated neuroendocrine tumors (NETs) with a good expression of somatostatin receptor (SSTR). Both o...

Deskribapen osoa

Gorde:
Egile Nagusiak: Anna Sowa-Staszczak, Marta Opalińska, Anna Kurzyńska, Karolina Morawiec-Sławek, Aleksandra Gilis-Januszewska, Joanna Palen-Tytko, Helena Olearska, Alicja Hubalewska-Dydejczyk
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2021-11-01
Saila:Medicina
Gaiak:
lanreotide
octreotide
self-administration
neuroendocrine tumors
treatment outcome
Sarrera elektronikoa:https://www.mdpi.com/1648-9144/57/12/1287
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak